Eric R. Bates – författare
Visar alla böcker från författaren . Handla med fri frakt och snabb leverans.
4 produkter
4 produkter
Inbunden, Engelska, 2008
2 770 kr
Skickas inom 10-15 vardagar
Reperfusion Therapy for Acute Myocardial Infarction provides a comprehensive review of reperfusion therapy for ST-segment elevation myocardial infarction (STEMI). Professor Eric R. Bates and his international team of contributors examine current and future reperfusion therapies for STEMI, in conjunction with the latest clinical trials and guidelines, to bring the most in-depth and thorough review of management strategies for these patients. This source addresses key developments that can reduce logistical barriers, improve times-to-treatment, and ensure that appropriate medications are administered in patient care.Demonstrating the benefits of reperfusion therapy, this volume: Examines fibrinolytic agents that can be used alone or in combination with other care regimens to improve the benefits of reperfusion therapy and reduce the risks of treatment Summarizes the use of percutaneous coronary intervention (PCI) across the spectrum of reperfusion therapy Helps specialists identify barriers to the early treatment of patients in various practice environments Reviews the clinical relevance and implications of recent clinical trials and the integration of these findings into the current practice of acute reperfusion therapy
E-bok
Engelska, 20163 290 kr
Läs direkt efter köp
Reperfusion Therapy for Acute Myocardial Infarction provides a comprehensive review of reperfusion therapy for ST-segment elevation myocardial infarction (STEMI). Professor Eric R. Bates and his international team of contributors examine current and future reperfusion therapies for STEMI, in conjunction with the latest clinical trials and guidelines, to bring the most in-depth and thorough review of management strategies for these patients. This source addresses key developments that can reduce logistical barriers, improve times-to-treatment, and ensure that appropriate medications are administered in patient care.Demonstrating the benefits of reperfusion therapy, this volume: Examines fibrinolytic agents that can be used alone or in combination with other care regimens to improve the benefits of reperfusion therapy and reduce the risks of treatment Summarizes the use of percutaneous coronary intervention (PCI) across the spectrum of reperfusion therapy Helps specialists identify barriers to the early treatment of patients in various practice environments Reviews the clinical relevance and implications of recent clinical trials and the integration of these findings into the current practice of acute reperfusion therapy.
E-bok
PDF, Engelska, 20163 290 kr
Läs direkt efter köp
Reperfusion Therapy for Acute Myocardial Infarction provides a comprehensive review of reperfusion therapy for ST-segment elevation myocardial infarction (STEMI). Professor Eric R. Bates and his international team of contributors examine current and future reperfusion therapies for STEMI, in conjunction with the latest clinical trials and guideline
Inbunden, Engelska, 2002
1 768 kr
Tillfälligt slut
This timely and comprehensive review is the only book to focus on the importance of treating cardiogenic shock as a discrete condition, not merely a symptom of another disease. The editors and authors are esteemed clinicians and investigators who have furthered our knowledge of the evaluation and management of cardiogenic shock. Contributors to this book comprise an international group of multidisciplinary specialists with extensive expertise in various aspects of cardiogenic shock, who have balanced their knowledge of pathophysiology and cutting-edge therapeutic approaches with their experience and unique perspectives. Practical management strategies based on the latest data from randomised trials of treatment strategies - including SHOCK, SMASH, and TACTICS - are discussed. Detailed reviews of related therapies such as ventricular assist devices, as well as special problems such as right ventricular myocardial infarction and rhythm disturbances, are provided. The future of potential metabolic support of the myocardium is presented.